Compare BHC & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHC | AMC |
|---|---|---|
| Founded | N/A | 1920 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 1996 | 2007 |
| Metric | BHC | AMC |
|---|---|---|
| Price | $6.52 | $2.59 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $8.00 | $2.03 |
| AVG Volume (30 Days) | 3.7M | ★ 20.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,724,000,000.00 | $4,848,900,000.00 |
| Revenue This Year | $4.61 | $11.41 |
| Revenue Next Year | N/A | $5.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.57 |
| 52 Week Low | $4.33 | $0.93 |
| 52 Week High | $8.00 | $3.18 |
| Indicator | BHC | AMC |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 53.04 |
| Support Level | $5.42 | $2.32 |
| Resistance Level | $7.24 | $3.00 |
| Average True Range (ATR) | 0.30 | 0.14 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 44.44 | 56.52 |
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.